IMGN
ImmunoGen Inc
Price:  
31.23 
USD
Volume:  
49,500,890.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMGN EV/EBITDA

-107.6%
Upside

As of 2024-05-20, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.3x - 16.1x 12.1x
Forward P/E multiples 14.2x - 20.1x 18.0x
Fair Price (2.15) - (2.68) (2.38)
Upside -106.9% - -108.6% -107.6%
31.23 USD
Stock Price
(2.38) USD
Fair Price

IMGN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA